Oxiracetam

Oxiracetam Research Standard

Oxiracetam (4-hydroxy-2-oxo-1-pyrrolidineacetamide) is a synthetic derivative of the piracetam family, characterized by the addition of a hydroxyl group to the pyrrolidone nucleus. This modification increases its potency compared to parent compounds, making it a staple in neuropharmacological research. Oxiracetam is primarily utilized as a specialized laboratory tool for investigating cognitive signaling pathways, specifically those related to cholinergic and glutamatergic neurotransmission, as well as cerebral energy metabolism in in vitro neural tissue models.

Technical Specifications

Mechanism of Action & Research Context

Oxiracetam is studied for its ability to modulate key neurotransmitter systems and metabolic processes within the brain, particularly in contexts involving high-density neural information processing.

• Cholinergic and Glutamatergic Modulation: Research indicates that oxiracetam may influence the release of acetylcholine and the modulation of glutamate receptors, which are essential for synaptic plasticity and the formation of long-term potentiation (LTP).

• Metabolic Enhancement: The compound is evaluated for its capacity to optimize oxygen and glucose utilization pathways in neural tissues, potentially stabilizing ATP production in cell-based energy models.

• Signaling Efficacy: By targeting these pathways, oxiracetam is used to measure the rate at which neural networks adapt and reorganize, providing a quantitative model for studying memory and learning efficiency.

Research Applications

Oxiracetam is a versatile reference compound utilized for exploring cognitive pathways in controlled laboratory settings.

Primary fields of in vitro laboratory investigation include:

• Neurotransmitter Activity Mapping: Measuring glutamate-related signaling dynamics and cholinergic transmission in cultured hippocampal tissue.

• Cellular Bioenergetics: Testing the compound’s influence on mitochondrial glucose uptake and oxygen consumption during metabolic stress.

• Synaptic Plasticity: Observing the speed and fidelity of information storage/retrieval in controlled neuronal network models.

• Cognitive Pharmacology: Serving as a benchmark for comparing the potency and activity profile of newer synthetic racetam derivatives.

Storage & Handling Guidelines

To maintain the chemical stability and experimental consistency of the compound:

• Storage Environment: Keep in a cool, dry place. Avoid exposure to high humidity, as moisture can compromise the stability of the capsules and powder.

• Thermal Protection: Keep away from heaters, hot laboratory equipment, or direct heat sources.

• Environmental Control: Keep in the original bottle to protect against light-induced degradation of the chemical bonds.

• Container Integrity: Ensure the container is closed tightly after every use to minimize atmospheric exposure.

References

• Valzelli L, et al. (1980) “Oxiracetam: a psychotropic drug with learning-enhancing properties.” Pharmacological Research Communications. 12(6): 579–583.

• Malykh AG, Sadaie MR. (2010) “Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders.” Drugs. 70(3): 287–312.

Research Use Disclaimer

Research Use Only Disclaimer: This product is developed and distributed strictly as a Research Use Only (RUO) laboratory reference chemical intended exclusively for non-clinical analytical and scientific investigation. It is not an FDA-approved drug, medical treatment, dietary supplement, or food ingredient, and is strictly prohibited for human or animal consumption. Kimera Chems supplies this high-purity research material solely to qualified institutions and professional investigators for authorized laboratory research.